REFERENCES
- Witmer A N, Vrensen G F, Van Noorden C J, Schlingemann R O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003; 22: 1–29, [PUBMED], [INFOTRIEVE], [CSA]
- Mathews M K, Merges C, McLeod D S, Lutty G A. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Invest Ophthalmol Vis Sci 1997; 38: 2729–2741, [PUBMED], [INFOTRIEVE], [CSA]
- Pe'er J, Folberg R, Itin A, et al. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. Br J Ophthalmol 1996; 80: 241–245, [PUBMED], [INFOTRIEVE], [CSA]
- Witmer A N, Blaauwgeers H G, Weich H A, et al. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Invest Ophthalmol Vis Sci 2002; 43: 849–857, [PUBMED], [INFOTRIEVE], [CSA]
- Kida T, Ikeda T, Nishimura M, et al. Renin-angiotensin system in proliferative diabetic retinopathy and its gene expression in cultured human muller cells. Jpn J Ophthalmol 2003; 47: 36–41, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Guidry C, Feist R, Morris R, Hardwick C W. Changes in IGF activities in human diabetic vitreous. Diabetes 2004; 53: 2428–2435, [PUBMED], [INFOTRIEVE], [CSA]
- Mitamura Y, Tashimo A, Nakamura Y, et al. Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Diabetes Care. 2002; 25: 2352, [PUBMED], [INFOTRIEVE], [CSA]
- Matsumoto Y, Takahashi M, Chikuda M, Arai K. Levels of mature cross-links and advanced glycation end product cross-links in human vitreous. Jpn J Ophthalmol 2002; 46: 510–517, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Wu C W, Sauter J L, Johnson P K, et al. Identification and localization of major soluble vitreous proteins in human ocular tissue. Am J Ophthalmol 2004; 137: 655–661, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Koyama R, Nakanishi T, Ikeda T, Shimizu A. Catalogue of soluble proteins in human vitreous humor by one-dimensional sodium dodecyl sulfate-polyacrylamide gel electrophoresis and electrospray ionization mass spectrometry including seven angiogenesis-regulating factors. J Chromatogr B 2003; 792: 5–21, [CSA], [CROSSREF]
- Yamane K, Minamoto A, Yamashita H, et al. Proteome analysis of human vitreous proteins. Mol Cell Proteomics 2003; 2: 1177–1187, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Nakanishi T, Koyama R, Ikeda T, Shimizu A. Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole. J Chromatogr B 2002; 776: 89–100, [CSA], [CROSSREF]
- Gorg A, Obermaier C, Boguth G, et al. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 2000; 21: 1037–1053, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Rabilloud T. Silver staining of 2-D electrophoresis gels. Methods Mol Biol 1999; 112: 297–305, [PUBMED], [INFOTRIEVE], [CSA]
- Rosenfeld J, Capdevielle J, Guillemot J C, Ferrara P. In-gel digestion of proteins for internal sequence analysis after one- or two-dimensional gel electrophoresis. Anal Biochem 1992; 203: 173–179, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850–858, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Scheler C, Lamer S, Pan Z, et al. Peptide mass fingerprint sequence coverage from differently stained proteins on two-dimensional electrophoresis patterns by matrix assisted laser desorption/ionization-mass spectrometry (MALDI-MS). Electrophoresis 1998; 19: 918–927, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cao W, Tombran-Tink J, Chen W, et al. Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 1999; 15: 789–800, [CSA], [CROSSREF]
- Cayouette M, Smith S B, Becerra S P, Gravel C. Pigment epithelium-derived factor delays the death of photoreceptors in mouse models of inherited retinal degenerations. Neurobiol Dis 1999; 6: 523–532, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Cao W, Tombran-Tink J, Elias R, et al. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest Ophthalmol Vis Sci 2001; 42: 1646–1652, [PUBMED], [INFOTRIEVE], [CSA]
- Dawson D W, Volpert O V, Gillis P, et al. Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245–258, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Spranger J, Osterhoff M, Reimann M, et al. Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes 2001; 50: 2641–2645, [PUBMED], [INFOTRIEVE], [CSA]
- Ogata N, Tombran-Tink J, Nishikawa M, et al. Pigment epithelium-derived factor in the vitreous is low in diabetic retinopathy and high in rhegmatogenous retinal detachment. Am J Ophthalmol 2001; 132: 378–382, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Apte R S, Barreiro R A, Duh E, et al. Stimulation of neovascularization by the anti-angiogenic factor PEDF. Invest Ophthalmol Vis Sci 2004; 45: 4491–4497, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Duh E J, Yang H S, Haller J A, et al. Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for ocular angiogenesis. Am J Ophthalmol 2004; 137: 668–674, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Gerhardinger C, Costa M B, Coulombe M C, et al. Expression of acute-phase response proteins in retinal muller cells in diabetes. Invest Ophthalmol Vis Sci 2005; 46: 349–357, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Bresgen M, Baum U, Esser P. Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis. Ophthalmologe 1994; 91: 758–762, [PUBMED], [INFOTRIEVE], [CSA]
- Gerashchenko D Y, Beuckmann C T, Marcheselli V L, et al. Localization of lipocalin-type prostaglandin D synthase (beta-trace) in iris, ciliary body, and eye fluids. Invest Ophthalmol Vis Sci 1998; 39: 198–203, [PUBMED], [INFOTRIEVE], [CSA]
- Beuckmann C T, Gordon W C, Kanaoka Y, et al. Lipocalin-type prostaglandin D synthase (beta-trace) is located in pigment epithelial cells of rat retina and accumulates within interphotoreceptor matrix. J Neurosci 1996; 16: 6119–6124, [PUBMED], [INFOTRIEVE], [CSA]
- Westphal M, Neuss M, Herrmann H D. Prostaglandins: Antiproliferative effect of PGD 2 on cultured human glioma cells. Acta Neurochir (Wien) 1986; 83: 56–61, [CSA], [CROSSREF]
- Stabach P R, Morrow J S. Identification and characterization of beta V spectrin, a mammalian ortholog of Drosophila beta H spectrin. J Biol Chem 2000; 275: 21385–21395, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Chew E Y, Klein M L, Ferris F L, 3rd, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch Ophthalmol. 1996; 114: 1079–1084, [PUBMED], [INFOTRIEVE], [CSA]
- Davis M D, Fisher M R, Gangnon R E, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Invest Ophthalmol Vis Sci 1998; 39: 233–252, [PUBMED], [INFOTRIEVE], [CSA]
- Verges B. Apolipoprotein A-IV in diabetes mellitus. Diabete Metab 1995; 21: 99–105, [PUBMED], [INFOTRIEVE], [CSA]
- Verges B, Vaillant G, Goux A, et al. Apolipoprotein A-IV levels and phenotype distribution in NIDDM. Diabetes Care 1994; 17: 810–817, [PUBMED], [INFOTRIEVE], [CSA]
- Ogata N, Nishikawa M, Nishimura T, et al. Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 2002; 134: 348–353, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]